ADM's clinical trial demonstrated that PRIOME MH postbiotic significantly reduced postprandial blood glucose levels in adult dogs during weight loss phases compared to placebo controls.
The Make America Healthy Again (MAHA) Commission has released a 73-page report identifying poor diet, environmental chemicals, sedentary lifestyles, and overmedicalization as key drivers of the childhood chronic disease crisis.
Novartis has partnered with BioAge Labs in a deal worth up to $550 million, gaining access to one of the world's largest human longevity datasets to develop treatments for age-related diseases.
Novo Nordisk CEO Lars Fruergaard Jørgensen announced his resignation after eight years leading the company through significant growth in the obesity treatment market.
Closed Loop Medicine has appointed Kate Woolland as CEO to lead the company's transition from product development to commercial deployment of its pharmaceutical precision dosing platform.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.